Fast Grants

Last updated

Fast Grants is an American charity that provides funding for scientific research. [1] The project was created in response to the COVID-19 pandemic to provide quick funding to scientists working on research projects that could help with the pandemic. [2]

Contents

History

The project was launched in April 2020 by Tyler Cowen, an economics professor at George Mason University; Patrick Collison, co-founder of online payment processing platform Stripe; and Patrick Hsu, a bioengineer at the University of California. [3]

Support

The project is supported by donations from Arnold Ventures, The Audacious Project, The Chan Zuckerberg Initiative, John Collison, Patrick Collison, Crankstart, Jack Dorsey, Kim and Scott Farquhar, Paul Graham, Reid Hoffman, Fiona McKean and Tobias Lütke, Yuri and Julia Milner, Elon Musk, Chris and Crystal Sacca, Schmidt Futures, and others. [4] [5]

Grants

Fast Grants provides funding between $10,000 and $500,000. The charity says they respond to applications within two days, and will also fund researchers outside the United States. [2]

As of April 2021, Fast Grants has awarded 250 grants totaling more than $50 million to researchers working on COVID-19 related projects, including testing, clinical work, surveillance, virology, drug development and trials, and PPE. [1] [6] Fast Grants provided initial funding for SalivaDirect, the saliva test used in the NBA “bubble” in Orlando during the 2020 season. [7] Other notable grant recipients include Addgene, the Center for Open Science, Susan Athey, Carolyn Bertozzi, Catherine Blish, Pamela Bjorkman, Susan Daniel, Barbara Engelhardt, Laura Esserman, Judith Frydman, Amy Gladfelter, Eva Harris, Akiko Iwasaki, Kevin Kain, Yoshihiro Kawaoka, Nevan Krogan, Ronald Levy, Allison McGeer, Miriam Merad, Keith Mostov, Mihai Netea, Daniel Nomura, Melanie Ott, Bradley Pentelute, Rosalind Picard, Hidde Ploegh, Angela Rasmussen, Erica Ollmann Saphire, Katherine Seley-Radtke, Erec Stebbins, Alice Ting, Alain Townsend, David Veesler, Bert Vogelstein, Tania Watts, and Qian Zhang. [4]

As of January 2022, new Fast Grants applications have been paused due to lack of additional funding. [8]

Related Research Articles

<span class="mw-page-title-main">The Biodesign Institute</span> Research center at Arizona State University

The Biodesign Institute is a major research center known for nature-inspired solutions to global health, sustainability, and security challenges located on the Tempe campus of Arizona State University. The institute is organized into a growing number of collaborative research centers and laboratories staffed by scientists in diverse disciplines. It is currently led by Executive Director Dr. Joshua LaBaer, a personalized diagnostics researcher.

EcoHealth Alliance is a US-based non-governmental organization with a stated mission of protecting people, animals, and the environment from emerging infectious diseases. The nonprofit focuses on research aimed at preventing pandemics and promoting conservation in hotspot regions worldwide.

Susan Fiona Dorinthea Michie is a British academic, clinical psychologist, and professor of health psychology, director of The Centre for Behaviour Change and head of The Health Psychology Research Group, all at University College London. She is also an advisor to the British Government via the SAGE advisory group on matters concerning behavioural compliance with government regulations during the COVID-19 pandemic. In 2022, she was appointed Chair of the World Health Organisation’s (WHO) Technical Advisory Group on Behavioural Insights and Sciences for Health.

<i>Our World in Data</i> Website that presents data and statistics of socially relevant topics

Our World in Data (OWID) is a scientific online publication that focuses on large global problems such as poverty, disease, hunger, climate change, war, existential risks, and inequality.

<span class="mw-page-title-main">COVID-19 testing</span> Diagnostic testing for SARS-CoV-2 virus infection

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.

<span class="mw-page-title-main">Impact of the COVID-19 pandemic on science and technology</span> Disruption to science, space and technology projects globally

The COVID-19 pandemic has affected innumerable scientific and technical institutions globally, resulting in lower productivity in a number of fields and programs. However, the impact of the pandemic has also led to the opening of several new research funding lines for government agencies around the world.

MusiCares' COVID-19 relief effort was a charitable initiative aimed at providing financial and other forms of assistance to musicians and music industry professionals affected by the COVID-19 pandemic. The initiative was established by MusiCares, a non-profit organization that was founded in 1989 by the Recording Academy, the organization behind the GRAMMY Awards.

Laura M. Lechuga Gómez is a Spanish scientist who is a biosensor researcher and full professor. She leads the Nanobiosensors and Bioanalytical Application Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2).

<span class="mw-page-title-main">British government response to the COVID-19 pandemic</span> UK government response to COVID-19

In response to the COVID-19 pandemic in the United Kingdom, the UK Government introduced various public health and economic measures to mitigate its impact. Devolution meant that the four nations' administrative responses to the pandemic differed; the Scottish Government, the Welsh Government, and the Northern Ireland Executive produced different policies to those that apply in England. Numerous laws were enacted or introduced throughout the crisis.

<span class="mw-page-title-main">Charitable activities related to the COVID-19 pandemic</span>

The COVID-19 pandemic has greatly impacted the international and domestic economies. Thus, many organizations, private individuals, religious institutions and governments have created different charitable drives, concerts and other events to lessen the economic impact felt.

<span class="mw-page-title-main">Peter Daszak</span> British zoologist

Peter Daszak is a British zoologist, consultant and public expert on disease ecology, in particular on zoonosis. He is the president of EcoHealth Alliance, a nonprofit non-governmental organization that supports various programs on global health and pandemic prevention. He is also a member of the Center for Infection and Immunity at the Columbia University Mailman School of Public Health. He lives in Suffern, New York.

<span class="mw-page-title-main">Zoe Health Study</span> COVID-19 mobile research app

The Zoe Health Study, formerly the COVID Symptom Study, is a health research project of British company Zoe Limited which uses a mobile app that runs on Android and iOS.

<span class="mw-page-title-main">Federal aid during the COVID-19 pandemic in Canada</span> National economic response to the COVID-19 pandemic

The Government of Canada introduced multiple temporary social security and financial aid programs in response to the economic impacts of the COVID-19 pandemic in Canada. The initial CA$82-billion aid package was announced on March 18, 2020 by Justin Trudeau.

<span class="mw-page-title-main">Coronavirus breathalyzer</span> Diagnostic medical device

A coronavirus breathalyzer is a diagnostic medical device enabling the user to test with 90% or greater accuracy the presence of severe acute respiratory syndrome coronavirus 2 in an exhaled breath. As of the first half of 2020, the idea of a practical coronavirus breathalyzer was concomitantly developed by unrelated research groups in Australia, Canada, Finland, Germany, Indonesia, Israel, Netherlands, Poland, Singapore, United Kingdom and USA.

Operation Moonshot was a UK government programme to introduce same-day mass testing for COVID-19 in England as a way of enabling large gatherings of people to take place in that country while maintaining control over the virus. According to the British Medical Journal, the programme aimed to deliver 10 million tests per day by 2021.

<span class="mw-page-title-main">Zhang Yongzhen</span> Chinese virologist

Zhang Yongzhen, also known as Yong-Zhen Zhang, is a Chinese virologist known for his work relating to the COVID-19 pandemic. A professor at Fudan University, Zhang has discovered numerous RNA viruses and created a network of labs dedicated to monitoring new viruses. He led the team that sequenced and published the genome of SARS-CoV-2, the virus that causes COVID-19, in early January 2020.

<span class="mw-page-title-main">History of COVID-19 vaccine development</span> Scientific work to develop a vaccine for COVID-19

SARS-CoV-2, the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations (CEPI), the geographic distribution of COVID‑19 vaccine development shows North American entities to have about 40% of the activity, compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.

<span class="mw-page-title-main">Impact of the COVID-19 pandemic on Native American tribes and tribal communities</span> Effects of the viral outbreak on tribal communities

The impact of the COVID-19 pandemic on Native American tribes and tribal communities has been severe and has emphasized underlying inequalities in Native American communities compared to the majority of the American population. The pandemic exacerbated existing healthcare and other economic and social disparities between Native Americans and other racial and ethnic groups in the United States. Along with black Americans, Latinos, and Pacific Islanders, the death rate in Native Americans due to COVID-19 was twice that of white and Asian Americans, with Native Americans having the highest mortality rate of all racial and ethnic groups nationwide. As of January 5, 2021, the mortality impact in Native American populations from COVID-19 was 1 in 595 or 168.4 deaths in 100,000, compared to 1 in 1,030 for white Americans and 1 in 1,670 for Asian Americans. Prior to the pandemic, Native Americans were already at a higher risk for infectious disease and mortality than any other group in the United States.

Software for COVID-19 pandemic mitigation takes many forms. It includes mobile apps for contact tracing and notifications about infection risks, vaccine passports, software for enabling – or improving the effectiveness of – lockdowns and social distancing, Web software for the creation of related information services, and research and development software. A common issue is that few apps interoperate, reducing their effectiveness.

<span class="mw-page-title-main">Anne Wyllie</span> New Zealand microbiologist and epidemiologist

Anne Louise Wyllie is a New Zealand microbiologist who was the lead author of a 2020 research article which led to the development of the SalivaDirect PCR method of testing saliva for SARS-CoV-2, the virus that causes COVID-19. She has also worked on community studies to better understand pneumococcal disease. She is a research scientist in epidemiology with the Public Health Modeling Unit at Yale University.

References

  1. 1 2 Hobson, Will. "Scientists wait months for coronavirus research grants. This economist is trying to fix that". The Washington Post. Retrieved 13 July 2020.
  2. 1 2 Piper, Kelsey (21 April 2020). "This new charity offers scientists coronavirus grants in 48 hours". Vox.
  3. Else, Holly (2021-08-03). "COVID 'Fast Grants' sped up pandemic science". Nature. doi:10.1038/d41586-021-02111-7. PMID   34345037. S2CID   236916209.
  4. 1 2 "Fast Grants". Fast Grants. Archived from the original on 2021-12-23. Retrieved 2023-05-21.
  5. "A group of tech billionaires is funding 'fast grants' of up to $500,000 for COVID-19 research, with every grant decision made in less than 48 hours". Business Insider. Retrieved 2022-01-18.
  6. "What We Learned Doing Fast Grants". Future. 15 June 2021. Retrieved 15 June 2021.
  7. "Yale-sponsored COVID-19 test was partially funded by Fast Grant program". George Mason University. Retrieved 2021-05-03.
  8. "Fast Grants". 2022-01-13. Archived from the original on 2022-01-13. Retrieved 2022-01-18.